NCT00101153View on ClinicalTrials.gov

Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2010

Conditions
Leukemia
Interventions
DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

tipifarnib

Trial Locations (2)

L8N 3Z5

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton

N6A 465

London Regional Cancer Program at London Health Sciences Centre, London

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University Health Network, Toronto

OTHER

NCT00101153 - Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter